Abstract
Objectives: Illicit drug use presents a significant challenge to global health and public safety, requiring innovative and effective monitoring strategies. This study aimed to evaluate the current landscape of wastewater-based epidemiology (WBE) for monitoring illicit drugs in Europe, focusing on collaboration, current practices, and barriers, while identifying opportunities for improvement. Study design: Cross-sectional survey-based study. Methods: Coordinated by the Sewage Analysis CORe Group Europe (SCORE) and the European Union Drugs Agency (EUDA), two surveys were conducted in 2023 targeting researchers and stakeholders using WBE for illicit drugs. Data were analysed to identify trends, gaps, and opportunities for improving WBE implementation. Results: The findings indicate a robust research infrastructure and diverse analytical methods among European institutions. Two-thirds of the participating countries reported using WBE data to inform policy. However, challenges persist, particularly in securing funding and coordination, as well as generating national estimates from multiple locations and addressing specific local policy needs. Conclusions: WBE has proven to be a valuable tool for monitoring illicit drug trends and informing drug policies. To unlock its full potential, sustained funding, methodological standardization, and enhanced cooperation are essential. This study provides critical insights into the European WBE landscape, offering a roadmap for strengthening the integration of actionable WBE data into public health and policy frameworks.
Original language | English |
---|---|
Pages (from-to) | 158-163 |
Number of pages | 6 |
Journal | Public Health |
Volume | 241 |
Early online date | 27 Feb 2025 |
DOIs | |
Publication status | E-pub ahead of print - 27 Feb 2025 |
Acknowledgements
LP Barron acknowledges the National Institute for Health and Care Research under the National Institute for Health and Care Research (NIHR) Health Protection Research Units in Chemical and Radiation Threats and Hazards, and Environmental Exposures and Health. M. Edland-Gryt acknowledges the support of Ingeborg Lund and Anne Line Bretteville-Jensen in the Norwegian part of this work. S. Castiglioni acknowledges the Department for Anti-Drug Policies, Prime Minister's Office, Rome, Italy for supporting national monitoring studies.Funding
J.A. Baz-Lomba acknowledges funding from European Union’s EU4Health programme under grant agreements 101140460 – EU-WISH. L. Bijlsma acknowledges grant RYC2020-028936-I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. M.G. Bertram acknowledges funding support from the Swedish Research Council Formas (2020-02293) and is a member of the COST Action ‘CA21111 - One Health drugs against parasitic vector-borne diseases in Europe and beyond (OneHealthdrugs). M. Lopez de Alda acknowledges the support of the Spanish (MCIN/AEI/10.13039/501100011033, RED2022-134363-T; Delegación del Gobierno para el Plan Nacional Sobre Drogas, 2020I009) and Catalonian Governments (2021 SGR 00753 and SA-2024-465).
Keywords
- Cooperation
- Europe
- Illicit drugs
- New psychoactive substances
- Policy
- Public health
- Wastewater-based Epidemiology
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health